Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Graupp, M; Schaffer, K; Wolf, A; Vasicek, S; Weiland, T; Pondorfer, P; Holzmeister, C; Moser, U; Thurnher, D.
C-reactive protein is an independent prognostic marker in patients with tongue carcinoma - A retrospective study.
Clin Otolaryngol. 2018; Doi: 10.1111/coa.13102 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Koiner-Graupp Matthias
Co-authors Med Uni Graz
Holzmeister Clemens
Moser Ulrich Christian
Pondorfer-Schäfer Prisca
Thurnher Dietmar
Vasicek Sarah Marvis
Weiland Thomas
Wolf Axel
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Reliable prognostic markers are lacking for tongue carcinoma. C-reactive protein (CRP) and a ratio from neutrophils/lymphocytes (NLR) are biomarkers, associated with prognosis in solid cancers. Aim of this work was to investigate the role of CRP and NLR in prognosis of patients with tongue carcinoma. Retrospective cohort study. We retrospectively analysed data of patients treated for tongue carcinoma at our institution. Levels of CRP, Neutrophils and Lymphocytes were measured pretherapeutic. 197 patients treated for squamous cell carcinoma of the tongue between 2002 and 2015. Overall survival, disease-free survival. Elevated CRP was significantly associated with shorter overall survival in our cohort in uni- and multivariate analysis. NLR was not associated with prognosis. In the present study we could confirm the role of CRP as an independent prognostic marker in patients with tongue carcinoma. Incorporating this marker in prognostication could represent a valuable and moreover inexpensive tool for improved decisions making concerning therapy in the future. © 2018 John Wiley & Sons Ltd.

Find related publications in this database (Keywords)
C-reactive protein
head and neck squamous cell carcinoma
neutrophile
lymphocyte ratio
prognostic markers
survival
tongue carcinoma
© Med Uni GrazImprint